fruquintinib
hutchmed
['fruquintinib', 'fresco-2', 'confirm,(-confirma),(-confirme),(-confirmi)']
 these results are very encouraging and confirm that fruquintinib may be a novel treatment opportunity for patients who previously had no other options, says our dr. arvind dasari of the findings of the global fresco-2 study: #esmo22 #endcancer
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789